Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and raises the price target from $63 to $65.
RBC Capital Downgrades GrafTech – Read Why
RBC Capital analyst Arun Viswanathan downgraded GrafTech International Ltd (NYSE:EAF) to Sector Perform from Outperform and lowered the price target to $7 (an…